BRPI1006451A2 - "sistema de tratamento bucal, método para a aplicação de um agente benéfico de tratamento bucal em uma superfície bucal, polipeptídeo e composição de tratamento bucal" - Google Patents

"sistema de tratamento bucal, método para a aplicação de um agente benéfico de tratamento bucal em uma superfície bucal, polipeptídeo e composição de tratamento bucal"

Info

Publication number
BRPI1006451A2
BRPI1006451A2 BRPI1006451A BRPI1006451A BRPI1006451A2 BR PI1006451 A2 BRPI1006451 A2 BR PI1006451A2 BR PI1006451 A BRPI1006451 A BR PI1006451A BR PI1006451 A BRPI1006451 A BR PI1006451A BR PI1006451 A2 BRPI1006451 A2 BR PI1006451A2
Authority
BR
Brazil
Prior art keywords
buccal
polypeptide
beneficial
applying
buccal treatment
Prior art date
Application number
BRPI1006451A
Other languages
English (en)
Inventor
Robert Anton Douglas
Wang Hong
A Fosser Kari
E Rouviere Pierre
Maria Gruber Tanja
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of BRPI1006451A2 publication Critical patent/BRPI1006451A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25—Silicon; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/29—Titanium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/42—Colour properties
    • A61K2800/43—Pigments; Dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60—Particulates further characterized by their structure or composition
    • A61K2800/61—Surface treated
    • A61K2800/614—By macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
BRPI1006451A 2009-03-30 2010-03-30 "sistema de tratamento bucal, método para a aplicação de um agente benéfico de tratamento bucal em uma superfície bucal, polipeptídeo e composição de tratamento bucal" BRPI1006451A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16447609P 2009-03-30 2009-03-30
PCT/US2010/029139 WO2010117753A2 (en) 2009-03-30 2010-03-30 Peptide compositions for oral care systems

Publications (1)

Publication Number Publication Date
BRPI1006451A2 true BRPI1006451A2 (pt) 2019-09-24

Family

ID=41821897

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1006451A BRPI1006451A2 (pt) 2009-03-30 2010-03-30 "sistema de tratamento bucal, método para a aplicação de um agente benéfico de tratamento bucal em uma superfície bucal, polipeptídeo e composição de tratamento bucal"

Country Status (7)

Country Link
US (2) US8481678B2 (pt)
EP (1) EP2413948A4 (pt)
JP (1) JP5850825B2 (pt)
CN (1) CN102448483A (pt)
AU (2) AU2010234816B2 (pt)
BR (1) BRPI1006451A2 (pt)
WO (2) WO2010114638A1 (pt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7807141B2 (en) 2003-09-08 2010-10-05 E.I. Du Pont De Nemours And Company Peptide-based oral care surface reagents for personal care
NZ585880A (en) 2007-12-07 2012-08-31 Vertex Pharma Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3] dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid
US8481678B2 (en) * 2009-03-30 2013-07-09 E I Du Pont De Nemours And Company Peptide-based tooth whitening reagents
US20150342839A1 (en) 2010-04-21 2015-12-03 Oraceutica LLC Compositions and methods for whitening teeth
US8568698B2 (en) 2010-08-24 2013-10-29 Safewhite Llc Methods and materials for providing teeth with a white appearance
EP2648650A1 (en) * 2010-12-07 2013-10-16 Colgate-Palmolive Company Apparatus for conducting oral care experiments and method of forming and using the same
CA2822422C (en) * 2010-12-20 2021-02-02 E. I. Du Pont De Nemours And Company Enzymatic peracid generation for use in oral care products
EP2707714B1 (en) * 2011-05-09 2019-10-09 Whitehead Institute For Biomedical Research Chaperone interaction assays and uses thereof
US9115182B2 (en) 2011-06-21 2015-08-25 E I Du Pont De Nemours And Company Cysteine cross-linked structural peptides
US9062312B2 (en) 2011-06-21 2015-06-23 Danisco Us Inc. Fusion peptides comprising multi-functional peptidic solubility tags for efficient production, processing and surface applications
EP2755626B1 (en) 2011-09-14 2017-08-16 Colgate-Palmolive Company Tooth whitening strip
AU2012355355B2 (en) 2011-12-19 2015-04-16 Colgate-Palmolive Company Peracid-generating compositions
MX354223B (es) 2011-12-19 2018-02-19 Colgate Palmolive Co Sistema que provee una reaccion catalizada por perhidrolasas.
CN108066306B (zh) 2012-01-25 2021-09-07 沃泰克斯药物股份有限公司 药物制剂及其制备方法
US8888489B2 (en) 2012-10-23 2014-11-18 Oraceutical Llc Method of simultaneously cleaning and whitening teeth
CN103408653B (zh) * 2013-08-15 2014-10-08 四川大学 一种仿生防龋多肽及其制备方法和用途
CN105555255B (zh) 2013-09-25 2019-07-12 克里登蒂斯股份公司 用于牙齿增白的牙科护理产品
EP2853256A1 (en) * 2013-09-25 2015-04-01 Credentis AG Dental care product for tooth whitening
MX385244B (es) * 2013-11-12 2025-03-14 Vertex Pharma Proceso para preparar composiciones farmaceuticas para el tratamiento de enfermedades mediadas por regulador de la conductancia transmembrana de la fibrosis quistica (cftr).
CN104027913B (zh) * 2014-06-06 2017-02-15 中国矿业大学(北京) 一种防止煤矸石自燃的复合氧化抑制剂及施用量
RU2701211C2 (ru) * 2014-12-19 2019-09-25 Колгейт-Палмолив Компани Устойчивая композиция в виде отбеливающего средства для чистки зубов с превосходными органолептическими свойствами
CA2994385C (en) * 2015-07-13 2021-01-19 Kabushiki Kaisha Sangi Powder containing apatite for forming a film on tooth surface
WO2017027488A1 (en) * 2015-08-10 2017-02-16 Oraceutical Llc Compositions and methods of whitening teeth
CN108348409B (zh) 2015-11-13 2021-06-18 宝洁公司 具有改善的氟化物稳定性的牙粉组合物
EP3373891B1 (en) * 2015-11-13 2022-08-31 The Procter & Gamble Company Dentifrice compositions with improved fluoride stability
EP3373892B1 (en) 2015-11-13 2021-04-28 The Procter & Gamble Company Dentifrice compositions with dual fluoride source with improved fluoride uptake
WO2017079957A1 (en) 2015-11-13 2017-05-18 The Procter & Gamble Company Dentifrice compositions with improved fluoride uptake
CN118221770A (zh) * 2017-07-10 2024-06-21 斯坦福国际研究院 分子导向系统肽及其用途
US11738089B2 (en) 2017-07-10 2023-08-29 Sri International Peptide saporin conjugate for the treatment of cancer
CN116898955A (zh) 2017-09-22 2023-10-20 旭化成制药株式会社 稳定性优异的含有特立帕肽的液态药物组合物
US20230174580A1 (en) * 2020-03-18 2023-06-08 Sri International Molecular transport system to the central nervous system
US11154470B1 (en) 2020-07-31 2021-10-26 vVardis AG Anti-inflammatory and senolytic dental care product with tooth whitening characteristics
EP3984517A1 (en) 2020-10-19 2022-04-20 Credentis AG Accelerating tooth remineralisation and bone regeneration with self-assembling peptides and amorphous calcium phosphate
CN115282083B (zh) * 2022-06-22 2025-07-29 仲恺农业工程学院 一种木质素基天然防晒复合物的制备方法

Family Cites Families (107)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2885366A (en) 1956-06-28 1959-05-05 Du Pont Product comprising a skin of dense, hydrated amorphous silica bound upon a core of another solid material and process of making same
US3961975A (en) 1975-01-07 1976-06-08 Eastman Kodak Company Titanium dioxide pigmented cellulosic polymer compositions with improved visible and ultraviolet light stability
US4430001A (en) 1979-12-26 1984-02-07 E. I. Du Pont De Nemours & Co. Injector mixer apparatus
US4494994A (en) 1983-03-28 1985-01-22 Seton Company Surface active agent compositions containing polypeptides and lignin sulfonic acid
US4780320A (en) * 1986-04-29 1988-10-25 Pharmetrix Corp. Controlled release drug delivery system for the periodontal pocket
JP2616786B2 (ja) 1987-12-24 1997-06-04 有限会社野々川商事 化粧料
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
DE3903362A1 (de) 1989-02-04 1990-08-09 Basf Ag Chemisch modifizierte proteine
JPH02311412A (ja) 1989-05-26 1990-12-27 Ichimaru Pharcos Co Ltd 動物又は植物由来ペプチドのカチオン化修飾物を含有する化粧料
DK0494955T3 (da) 1989-10-05 1998-10-26 Optein Inc Cellefri syntese og isolering af hidtil ukendte gener og polypeptider
AU641736B2 (en) 1990-03-21 1993-09-30 Quest International B.V. Delivery of agents
GB9021671D0 (en) 1990-10-05 1990-11-21 Unilever Plc Delivery of agents
US5085698A (en) 1990-04-11 1992-02-04 E. I. Du Pont De Nemours And Company Aqueous pigmented inks for ink jet printers
EP0546049B1 (en) 1990-08-28 1995-07-19 E.I. Du Pont De Nemours And Company A method for rapid selection of efficient secretion vectors
US5449754A (en) 1991-08-07 1995-09-12 H & N Instruments, Inc. Generation of combinatorial libraries
US5639603A (en) 1991-09-18 1997-06-17 Affymax Technologies N.V. Synthesizing and screening molecular diversity
US5231131A (en) 1991-12-24 1993-07-27 E. I. Du Pont De Nemours And Company Aqueous graft copolymer pigment dispersants
EP0556649B1 (en) 1992-02-20 1999-06-23 E.I. Du Pont De Nemours & Company Incorporated Aqueous dispersions containing ABC triblock polymer dispersants
EP0644938A1 (en) 1992-05-29 1995-03-29 E.I. Du Pont De Nemours And Company PRODUCTION OF STREPTAVIDIN FROM $i(BACILLUS SUBTILIS)
US5585275A (en) 1992-09-02 1996-12-17 Arris Pharmaceutical Corporation Pilot apparatus for peptide synthesis and screening
DE4235996A1 (de) 1992-10-24 1994-04-28 Degussa Flammenhydrolytisch hergestelltes Titandioxid-Mischoxid, Verfahren zu seiner Herstellung und Verwendung
US5480971A (en) 1993-06-17 1996-01-02 Houghten Pharmaceuticals, Inc. Peralkylated oligopeptide mixtures
US5609671A (en) 1994-06-20 1997-03-11 Orient Chemical Industries, Ltd. Water-based pigment ink and process for producing the same
US5554739A (en) 1994-12-15 1996-09-10 Cabot Corporation Process for preparing carbon materials with diazonium salts and resultant carbon products
US5571311A (en) 1994-12-15 1996-11-05 Cabot Corporation Ink jet ink formulations containing carbon black products
IL116379A (en) 1994-12-15 2003-12-10 Cabot Corp Aqueous inks and coatings containing modified carbon products
US6852156B2 (en) 2000-06-05 2005-02-08 E.I. Du Pont De Nemours And Company Self-dispersing pigment and process of making and use of same
DE69623158T2 (de) 1995-03-20 2003-04-30 Orient Chemical Industries, Ltd. Verfahren zur Herstellung einer wässrigen pigmenthaltigen Tinte
EP0736544B1 (en) 1995-04-05 2001-10-24 Unilever Plc Oral care compositions
JPH11512019A (ja) 1995-08-29 1999-10-19 イー・アイ・デユポン・ドウ・ヌムール・アンド・カンパニー 固体粒子を被覆する装置及び方法
US5846307A (en) 1996-04-19 1998-12-08 Orient Chemical Industries, Ltd. Aqueous pigment ink composition
US5922118A (en) 1996-06-14 1999-07-13 Cabot Corporation Modified colored pigments and ink jet inks, inks, and coatings containing modified colored pigments
US5747562A (en) 1996-06-14 1998-05-05 Cabot Corporation Ink and coating compositions containing silicon-treated carbon black
US5707432A (en) 1996-06-14 1998-01-13 Cabot Corporation Modified carbon products and inks and coatings containing modified carbon products
US5698016A (en) 1996-06-14 1997-12-16 Cabot Corporation Compositions of modified carbon products and amphiphilic ions and methods of using the same
US5837045A (en) 1996-06-17 1998-11-17 Cabot Corporation Colored pigment and aqueous compositions containing same
US5962641A (en) 1996-08-16 1999-10-05 Clontech Laboratories, Inc. Method for purification of recombinant proteins
US5928419A (en) 1996-10-07 1999-07-27 Toyo Ink Manufacturing Co., Ltd. Surface-treated organic pigment and process for the production thereof
WO1998016191A1 (en) 1996-10-11 1998-04-23 Novo Nordisk A/S CELLULOSE BINDING DOMAINS (CBDs) FOR ORAL CARE PRODUCTS
KR100536796B1 (ko) 1996-12-26 2005-12-14 미쓰비시 가가꾸 가부시키가이샤 카본블랙, 그 제조방법 및 이를 함유하는 수성분산액 및수성잉크
PT971946E (pt) 1997-01-21 2006-11-30 Gen Hospital Corp Selecção de proteínas utilizando fusões arn-proteína
US6261804B1 (en) 1997-01-21 2001-07-17 The General Hospital Corporation Selection of proteins using RNA-protein fusions
US6329446B1 (en) 1997-06-05 2001-12-11 Xerox Corporation Ink composition
US5895522A (en) 1997-08-12 1999-04-20 Cabot Corporation Modified carbon products with leaving groups and inks and coatings containing modified carbon products
JP3862441B2 (ja) 1998-03-20 2006-12-27 キヤノン株式会社 インクジェット記録用インク、インクセット、インクカートリッジ、記録ユニット、画像記録装置、画像記録方法、カラー画像の形成方法および画像の光学濃度向上方法
US6291023B1 (en) 1998-04-22 2001-09-18 Sri International Method and composition for textile printing
US6846655B1 (en) 1998-06-29 2005-01-25 Phylos, Inc. Methods for generating highly diverse libraries
EP1105516A4 (en) 1998-08-17 2002-01-09 Phylos Inc METHODS FOR PRODUCING PRIVATE NUCLEIC ACIDS FROM 3 'NON-TRANSLATED REGIONS AND FOR OPTIMIZING THE FORMATION OF A CELL-PROTEIN RNA FUSION
AU757955B2 (en) 1998-08-17 2003-03-13 Bristol-Myers Squibb Company Identification of compound-protein interactions using libraries of protein-nucleic acid fusion molecules
US6287374B1 (en) 1998-09-11 2001-09-11 Shozo Yanagida Pigment and process for producing the same, water base ink and process for producing the same
US6375317B1 (en) 1998-10-27 2002-04-23 Canon Kabushiki Kaisha Ink, ink-jet recording process, recording unit, ink cartridge and ink-jet recording apparatus
US6281267B2 (en) 1998-10-29 2001-08-28 Hewlett-Packard Company Ink to ink bleed and halo control using specific polymers in ink-jet printing inks
ATE354675T1 (de) 1998-12-02 2007-03-15 Adnexus Therapeutics Inc Dna-protein fusionen sowie anwendungen derselben
DK1157069T3 (da) 1999-03-05 2003-09-01 Cabot Corp Fremgangsmåde til fremstilling af farvede pigmenter
ATE376574T1 (de) 1999-03-12 2007-11-15 Cabot Corp Kationische pigmente und diese enthaltende wässrige zusammensetzungen
US6323257B1 (en) 1999-04-23 2001-11-27 Hewlett-Packard Company Ink-jet ink compositions containing reactive macromolecular chromophores for digital and textile printing
EP1120446A4 (en) 1999-06-09 2007-10-31 Orient Chemical Ind Aqueous pigment dispersion and method for producing the same
US6221142B1 (en) 1999-06-18 2001-04-24 Hewlett-Packard Company Superior waterfastness and bleed control with specifically treated pigments for ink-jet printing
WO2001007009A1 (en) 1999-07-22 2001-02-01 Pericor Science, Inc. Lysine oxidase linkage of agents to tissue
KR20020033743A (ko) 1999-07-27 2002-05-07 추후기재 펩티드 수용체 리게이션 방법
CA2382545C (en) 1999-08-27 2013-08-13 Phylos, Inc. Methods for encoding and sorting in vitro translated proteins
AU1353401A (en) 1999-10-28 2001-05-08 Cabot Corporation Ink jet inks, inks, and other compositions containing colored pigments
DE19954260A1 (de) 1999-11-11 2001-06-28 Degussa Wäßrige Rußdispersionen
DK1268766T3 (da) 2000-03-31 2006-04-10 Cambridge Antibody Tech Forbedringer af ribosom-display
US7129326B2 (en) 2000-04-14 2006-10-31 Genencor International, Inc. Methods for selective targeting
DK1360500T3 (da) 2000-04-14 2010-05-25 Genencor Int Fremgangsmåde til selektiv målretning
JP2002363026A (ja) 2000-06-02 2002-12-18 Nihon Kolmar Co Ltd 化粧剤の吸着を増強させる方法および化粧料
WO2002092028A2 (en) 2001-05-15 2002-11-21 The Procter & Gamble Company Oral care compositions
DE60229745D1 (de) 2001-06-25 2008-12-18 Procter & Gamble Mundpflegezusammensetzungen
US6402825B1 (en) 2001-07-27 2002-06-11 Lexmark International, Inc Surface modified carbon black
WO2003031477A1 (en) 2001-10-03 2003-04-17 Unilever N.V. Carbohydrate binding domain containing fusion proteins for delivery of therapeutic and other agents, and compositions containing them
ES2327398T3 (es) 2001-11-20 2009-10-29 Duke University Biomateriales interfaciales.
DE10227238A1 (de) 2002-06-19 2004-01-15 Wella Ag Hochaffine kosmetische Mittel
AU2003294266A1 (en) 2002-11-25 2004-06-18 Genencor International, Inc. Skin or hair binding peptides
EP1470824A1 (en) 2002-12-10 2004-10-27 L-MAbs B.V. Affinity proteins for controlled application of cosmetic substances
US20050069501A1 (en) 2003-08-15 2005-03-31 Sayed Ibrahim Rapid temporary tooth whitening composition
US7585495B2 (en) 2003-09-08 2009-09-08 E. I. Du Pont De Nemours And Company Method for identifying shampoo-resistant hair-binding peptides and hair benefit agents therefrom
US7807141B2 (en) 2003-09-08 2010-10-05 E.I. Du Pont De Nemours And Company Peptide-based oral care surface reagents for personal care
US20050054752A1 (en) 2003-09-08 2005-03-10 O'brien John P. Peptide-based diblock and triblock dispersants and diblock polymers
US7220405B2 (en) * 2003-09-08 2007-05-22 E. I. Du Pont De Nemours And Company Peptide-based conditioners and colorants for hair, skin, and nails
US7285264B2 (en) * 2003-09-08 2007-10-23 E.I. Du Pont De Nemours And Company Peptide-based body surface coloring reagents
US7309482B2 (en) 2003-09-08 2007-12-18 E.I. Du Pont De Nemours And Company Long lasting waterproof sunscreen comprising metal oxide and peptide conditioner
US20050226839A1 (en) 2003-09-08 2005-10-13 Xueying Huang Pepetide-based body surface reagents for personal care
EP2248884A1 (en) 2004-07-22 2010-11-10 The Procter & Gamble Company Detergent Compositions Comprising Coloured Particles
US8022040B2 (en) * 2004-11-29 2011-09-20 The Regents Of The University Of California Hydroxyapatite-binding peptides for bone growth and inhibition
WO2006068011A1 (ja) 2004-12-22 2006-06-29 Lion Corporation 歯牙美白用組成物及び歯牙美白用セット
US20060199206A1 (en) 2005-03-01 2006-09-07 Hong Wang Method for identifying skin care composition-resistant skin-binding peptides
US20070196305A1 (en) 2005-03-01 2007-08-23 Hong Wang Method for identifying hair conditioner-resistant hair-binding peptides and hair benefit agents therefrom
DE102005029704A1 (de) 2005-06-24 2007-01-11 Basf Ag Verwendung von Hydrophobin-Polypeptiden sowie Konjugaten aus Hydrophobin-Polypeptiden mit Wirk-oder Effektstoffen und ihre Herstellung sowie deren Einsatz in der Kosmetik
US20070065387A1 (en) * 2005-09-16 2007-03-22 Beck William A Method for enhancing the effect of particulate benefit agents
AU2006294578B2 (en) * 2005-09-28 2013-02-07 The Regents Of The University Of California Calcium binding peptides
US8318659B2 (en) 2005-11-15 2012-11-27 E I Du Pont De Nemours And Company Peptide-based organic sunscreens
US7928076B2 (en) 2005-12-15 2011-04-19 E. I. Du Pont De Nemours And Company Polypropylene binding peptides and methods of use
US7700716B2 (en) 2005-12-15 2010-04-20 E. I. Du Pont De Nemours And Company Polytetrafluoroethylene binding peptides and methods of use
US7632919B2 (en) 2005-12-15 2009-12-15 E.I. Du Pont De Nemours And Company Polystyrene binding peptides and methods of use
US7709601B2 (en) 2005-12-15 2010-05-04 E. I. Du Pont De Nemours And Company Nylon binding peptides and methods of use
US7906617B2 (en) 2005-12-15 2011-03-15 E. I. Du Pont De Nemours And Company Polyethylene binding peptides and methods of use
US7858581B2 (en) 2005-12-15 2010-12-28 E. I. Du Pont De Nemours And Company PMMA binding peptides and methods of use
US20080280810A1 (en) * 2006-10-30 2008-11-13 O'brien John P Peptides having affinity for body surfaces
US20080107614A1 (en) 2006-11-06 2008-05-08 Fahnestock Stephen R Peptide-based conditioners
US20080175798A1 (en) 2006-12-11 2008-07-24 Beck William A Peptide-based hair protectants
US7951559B2 (en) 2007-07-25 2011-05-31 E.I. Du Pont De Nemours And Company Recombinant peptide production using a cross-linkable solubility tag
US7754680B2 (en) * 2007-07-26 2010-07-13 E. I. Du Pont De Nemours And Company Peptides for binding calcium carbonates and methods of use
US8263056B2 (en) 2007-09-14 2012-09-11 E I Du Pont De Nemours And Company Dyed-hair-binding peptides and peptide-based hair reagents for personal care
US20100158822A1 (en) 2008-12-18 2010-06-24 E .I. Du Pont De Nemours And Company Peptides that bind to silica-coated particles
US8697654B2 (en) 2008-12-18 2014-04-15 E I Du Pont De Nemours And Company Peptide linkers for effective multivalent peptide binding
US8481678B2 (en) * 2009-03-30 2013-07-09 E I Du Pont De Nemours And Company Peptide-based tooth whitening reagents

Also Published As

Publication number Publication date
AU2016210634A1 (en) 2016-08-18
JP2012522059A (ja) 2012-09-20
WO2010117753A2 (en) 2010-10-14
AU2010234816A1 (en) 2011-09-15
WO2010114638A1 (en) 2010-10-07
US8354381B2 (en) 2013-01-15
US20100247457A1 (en) 2010-09-30
JP5850825B2 (ja) 2016-02-03
WO2010117753A3 (en) 2011-01-27
CN102448483A (zh) 2012-05-09
EP2413948A2 (en) 2012-02-08
AU2010234816B2 (en) 2016-08-25
EP2413948A4 (en) 2013-07-17
US8481678B2 (en) 2013-07-09
US20100247589A1 (en) 2010-09-30

Similar Documents

Publication Publication Date Title
BRPI1006451A2 (pt) "sistema de tratamento bucal, método para a aplicação de um agente benéfico de tratamento bucal em uma superfície bucal, polipeptídeo e composição de tratamento bucal"
BRPI0809674A2 (pt) Formulação aquosa estéril, estável, forma de dosagem unitária farmacêutica, recipiente selado, kit, método para prevenir, controlar, tratar ou melhorar uma doença ou distúrbio inflamatório, composição, processo para a preparação de uma composição, e, método para estabilizar um anticorpo 13h5
BRPI0916820A2 (pt) processo para preparar microcápsulas, microcápsulas, composição, método para tratar uma condição de superfície em um paciente, e, uso de microcápsulas
IL244293A0 (en) Pharmaceutical preparation and method of treatment for emergency contraception
BRPI1008076A2 (pt) sistema, método e aparelho para implementar implantes dentários
ZA201008030B (en) Method and composition for skin inflammation and discoloration
BR112013003529A2 (pt) "composição aerada, composição de tratamento capilar método para o tratamento capilar"
SG10201408158SA (en) Composition and methods used during anti-hiv treatment
IL225597A0 (en) Pharmaceutical preparation, methods of treatment and its uses
BRPI1006145A2 (pt) "composição e método para tratamento de diabetes".
EP2271390A4 (en) MONORAIL NEURO MICRO CATHETER FOR DISTRIBUTING MEDICAL DEVICES FOR THE TREATMENT OF STROKE, PROCESSES AND PRODUCTS
ZA201009184B (en) Composition and method for enhancing flouride uptake using bioactive glass
ZA201006586B (en) Plant disease controlling composition and method for controlling plant disease
BRPI1007477A2 (pt) método, e, composição de tratamento de poço
ZA201101818B (en) Modified release emulsions for application to skin or viginal mucosa
BRPI0906461A2 (pt) Composição para o cuidado oral, e, método para aplicar uma composição de cuidado oral na cavidade oral
EP2593109A4 (en) METHOD AND FORMULATIONS FOR THE TREATMENT OF SIALIC ACID DEFICIENCIES
BRPI0924652A2 (pt) composição dentifrícea, e, método para tratar ou prevenir dano erosivo a uma superfície de esmalte de um dente
BRPI0916446A2 (pt) dispositivo, sistema, composição e método para a distribuição de uma composição de dióxido de cloro substancialmente isenta de ânion de oxi- cloro a um tecido
LT2510980T (lt) Dermokosmetinis odos gydymo būdas, taikant ngf turinčias kompozicijas
ZA201303222B (en) Composition and method for treating skin conditions
EP2345416A4 (en) PHARMACEUTICAL COMPOSITION FOR CLEANING VENES AND MANUFACTURING METHOD THEREFOR
GB2469220B (en) Pharmaceutical composition for treating diabetes and preparation method thereof
IL211904A0 (en) Composition for treating disese
EP2450038A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DIABETIC NEUROPATHY AND MANUFACTURING AND USE METHODS

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.